Atila Biosystems
Non-Invasive Prenatal Test Kits
Description:
Noninvasive prenatal testing (NIPT) is a method to assess the risk that the fetus will be born with certain genetic abnormalities. Most common NIPT is for aneuploidy of a chromosome which is caused by the presence of an extra or missing copy of a chromosome. The test primarily looks for Down syndrome (trisomy 21), Edwards Syndrome (trisomy 18), and Patau Syndrome (trisomy 13). The test also provides fetal fraction determination.
The Atila Non-Invasive Prenatal Test (NIPT) Kit screens for aneuploidy of chromosomes 21, 18, and 13 in singleton pregnancies. The kit combines Atila’s extreme multiplex PCR technology and the Digital PCR system to accurately quantify the copy numbers of chromosome 21, 18, and 13 in maternal blood cell-free DNA (cfDNA).
Key Features:
- Highly multiplexed PCR: Enables simultaneous quantification of the chromosome 21, 18, 13, and 1, and the fetal fraction.
- Simple procedures: Direct Digital PCR amplification on purified cfDNA
- Simple data analysis: No complicated bioinformatics required
Technical Specs:
Sample Types: purified maternal cfDNA
Assay Time: 3 hours
Hands-On Time: 30 minutes
System Compatibility: Digital PCR System
Method: Multiplex Digital PCR
Resources:
*Order Information:
- NIPT-100Q NIPT kit for For Trisomy 21, Trisomy 18, Trisomy 13 Detection, and Fetal Fraction Determination 100 reactions
- NIPT-Y-100Q NIPT Gender Determination and Fetal Fraction Assay 100 reactions
- NIPT-GS-100Q NIPT Genomic DNA Contamination Assay 100 reactions
* These products are for research use only.